BioCardia (BCDA) Shares Outstanding (2015 - 2026)

BioCardia (BCDA) has reported Shares Outstanding (Entity) for 12 consecutive years, with $12.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 119.69% year-over-year to $12.1 million in Q2 2026; TTM through Jun 2026 was $12.1 million, a 119.69% increase from a year earlier, with the FY2025 full-year figure at $6.7 million, up 142.98% from the prior year.
• Shares Outstanding (Entity) was $12.1 million for Q2 2026 at BioCardia, up from $10.9 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $12.1 million in Q2 2026 and troughed at $1.1 million in Q1 2022.
• A 5-year average of $3.7 million and a median of $2.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) grew 0.47% in 2022 and soared 161.69% in 2025, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $1.3 million in 2022, then climbed by 17.88% to $1.6 million in 2023, then soared by 73.9% to $2.7 million in 2024, then surged by 142.98% to $6.7 million in 2025, then surged by 81.39% to $12.1 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $12.1 million (Q2 2026), $10.9 million (Q1 2026), and $6.7 million (Q4 2025), per Business Quant data.